Advertisement
News
Subscribe to MDT Magazine News

New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 21, 2011 /- Masimo (NASDAQ: MASI ) announced today that a new study published in this month's issue of the peer-reviewed journal, Annals of Emergency Medicine, demonstrates that noninvasive Masimo carboxyhemoglobin (SpCO®) measurements provide an "effective...

TOPICS:

Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass., April 21, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET. A live webcast of the...

TOPICS:

iMD Companies, Inc. Acquires OMI LLC and Files Financials for 2010

April 21, 2011 8:33 am | Comments

TAMPA, Fla., April 21, 2011 /- iMD Companies (ICBU.PK) is pleased to announce that is has acquired an Independent Diagnostic Testing Facility (IDTF), Optimum Mobile Imaging LLC, which increases and diversifies the Company's portfolio of Medical Service businesses.  The acquisition...

Advertisement

Cepheid swings to profit in 1st quarter

April 21, 2011 7:45 am | by The Associated Press | Comments

Shares of molecular diagnostics company Cepheid were flat Thursday despite stronger-than-expected quarterly results.THE SPARK: The Sunnyvale, Calif., company reported a profit of $527,000, or a penny per share, in the first quarter of 2011. A year ago Cepheid took a loss of $4.3 million, or 7...

Baxter International reports 1Q profit

April 21, 2011 7:45 am | by The Associated Press | Comments

Drug and medical device maker Baxter International Inc. on Thursday reported a profit in the first quarter on a mix of higher sales and lower costs, and the company boosted its full-year financial outlook.The company earned $577 million, or 98 cents per share, compared with a loss of $60...

Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

BRANFORD, Conn., April 21, 2011 /- Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced commencement of a proof-of-concept clinical trial of its lead candidate ganaxolone for the treatment of posttraumatic...

TOPICS:

Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

RENO, Nev., April 21, 2011 /- Sanare, LLC, a leading provider of care management solutions for people with diabetes, and its new consumer brand, BrightSky, have become National Strategic Partners of the American Diabetes Association.® (Logo:...

TOPICS:

ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®

April 21, 2011 6:34 am | by Bio-Medicine.Org | Comments

IRVINGTON, N.Y., April 21, 2011 /- ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMA SORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada. HEMA SORB is a ready-to-use,...

TOPICS:
Advertisement

Amgen says it will pay dividend starting in 2Q

April 21, 2011 5:45 am | by The Associated Press | Comments

Biotechnology company Amgen Inc. says it will start paying a quarterly dividend in the second quarter, and plans to pay about 20 percent of its adjusted annual profit in dividends.The Thousand Oaks, Calif., company had been expected to declare its first dividend. It says it will raise its...

Biogen Q1 numbers up on strength of MS drug sales

April 21, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Biogen Idec Inc. said first-quarter revenue was up 9 percent over the same period a year earlier, driven by the performance of its two blockbuster multiple sclerosis infusion treatments.

Reportlinker Adds Medical Equipment Monthly Deals Analysis - M & A and Investment Trends, April 2011

April 21, 2011 5:32 am | by Bio-Medicine.Org | Comments

NEW YORK, April 21, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011...

TOPICS:

Tooling U Relocates to New Brick and Mortar Site

April 21, 2011 4:37 am | by Society of Manufacturing Engineers | Comments

CLEVELAND, Ohio, April 21, 2010 — Tooling U, the leading developer of online manufacturing training, has relocated its headquarters to Tyler Village — one of Cleveland's largest-ever downtown redevelopment projects. More

Brooks sells Oregon unit to Celestica for $80M

April 21, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Chelmsford semiconductor technology maker Brooks Automation Inc. has decided to sell a contract manufacturing business unit based in Oregon for $80 million in cash to Canadian firm Celestica Inc.

UnitedHealth's 1Q profit climbs 13 percent

April 21, 2011 2:45 am | by The Associated Press | Comments

UnitedHealth Group says its first-quarter net income rose 13 percent, led by revenue gains in commercial health insurance. The managed care company also raised its full-year earnings forecast.The Minnetonka, Minn., insurer says it earned $1.34 billion, or $1.22 per share, in the three months...

Reportlinker Adds Europe ENT Devices Market Outlook to 2017

April 21, 2011 2:33 am | by Bio-Medicine.Org | Comments

NEW YORK, April 21, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Europe ENT Devices Market Outlook to 2017 http://www.reportlinker.com/p0333693/Europe-ENT-Devices-Market-Outlook-to-2017.html Europe ENT Devices Market Outlook to 2017...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading